{"log_id": 1894225653757390855, "direction": 0, "words_result_num": 26, "words_result": [{"probability": {"variance": 0, "average": 0.999601, "min": 0.999357}, "location": {"width": 125, "top": 200, "height": 30, "left": 190}, "words": "肝功能不全"}, {"probability": {"variance": 3.4e-05, "average": 0.995519, "min": 0.982717}, "location": {"width": 149, "top": 247, "height": 29, "left": 192}, "words": "磷酸西格列汀"}, {"probability": {"variance": 0.002181, "average": 0.980463, "min": 0.787366}, "location": {"width": 834, "top": 277, "height": 50, "left": 190}, "words": "中度肝功能不全( Child-Pugh评分7~9分)的患者在服用了磷酸西格列汀100mg"}, {"probability": {"variance": 0.000872, "average": 0.98909, "min": 0.842267}, "location": {"width": 830, "top": 325, "height": 50, "left": 192}, "words": "以后,西格列汀的平均AUC和Cmax与对照组的健康受试者相比分别高出了21%和"}, {"probability": {"variance": 0.004267, "average": 0.980705, "min": 0.704686}, "location": {"width": 449, "top": 380, "height": 43, "left": 200}, "words": "3%。目前认为这种差别可能没有临床意义"}, {"probability": {"variance": 0.001845, "average": 0.98286, "min": 0.798341}, "location": {"width": 829, "top": 420, "height": 51, "left": 195}, "words": "目前还没有关于重度肝功能不全( Child-Pugh评分>9分)患者的资料。但由于西"}, {"probability": {"variance": 6.1e-05, "average": 0.997434, "min": 0.953412}, "location": {"width": 831, "top": 469, "height": 48, "left": 195}, "words": "格列汀主要是通过肾脏清除,因此严重的肝功能不全应当不会影响西格列汀的药"}, {"probability": {"variance": 0, "average": 0.999605, "min": 0.999142}, "location": {"width": 101, "top": 532, "height": 30, "left": 198}, "words": "代动力学"}, {"probability": {"variance": 0.026772, "average": 0.916252, "min": 0.552452}, "location": {"width": 146, "top": 621, "height": 29, "left": 203}, "words": "盐酸二甲双胍"}, {"probability": {"variance": 8e-06, "average": 0.998214, "min": 0.987552}, "location": {"width": 598, "top": 656, "height": 43, "left": 202}, "words": "目前尚无二甲双胍在肝功能不全患者中的药代动力学研究"}, {"probability": {"variance": 1.1e-05, "average": 0.995728, "min": 0.992388}, "location": {"width": 53, "top": 758, "height": 28, "left": 206}, "words": "性别"}, {"probability": {"variance": 3e-05, "average": 0.995964, "min": 0.985003}, "location": {"width": 146, "top": 804, "height": 28, "left": 210}, "words": "磷酸西格列汀"}, {"probability": {"variance": 0.005832, "average": 0.9759, "min": 0.652657}, "location": {"width": 830, "top": 834, "height": 47, "left": 206}, "words": "基于对I期药代动力学数据的综合分析以及I期和Ⅱ期数据的人口药代动力学分"}, {"probability": {"variance": 2.7e-05, "average": 0.997306, "min": 0.978766}, "location": {"width": 623, "top": 886, "height": 42, "left": 207}, "words": "析,性别对于西格列汀的药代动力学没有具临床意义的影响"}, {"probability": {"variance": 8.9e-05, "average": 0.971337, "min": 0.96192}, "location": {"width": 99, "top": 947, "height": 48, "left": 906}, "words": "药经"}, {"probability": {"variance": 0.020583, "average": 0.929198, "min": 0.608636}, "location": {"width": 144, "top": 987, "height": 29, "left": 213}, "words": "盐酸二甲双胍"}, {"probability": {"variance": 0.003159, "average": 0.983361, "min": 0.69443}, "location": {"width": 828, "top": 1018, "height": 47, "left": 212}, "words": "从性别角度分析发现正常受试者和2型糖尿病患者的二甲双胍药代动力学参数没"}, {"probability": {"variance": 0.005374, "average": 0.980433, "min": 0.573564}, "location": {"width": 829, "top": 1063, "height": 48, "left": 213}, "words": "有显著差异。同样的,在2型糖尿病患者中开展的对照临床研究表明,甲双抓"}, {"probability": {"variance": 1e-06, "average": 0.999043, "min": 0.995576}, "location": {"width": 527, "top": 1117, "height": 40, "left": 214}, "words": "的抗高血糖效果在男性患者与女性患者中是相似的"}, {"probability": {"variance": 0, "average": 0.999793, "min": 0.999735}, "location": {"width": 100, "top": 1216, "height": 27, "left": 221}, "words": "老年患者"}, {"probability": {"variance": 2e-06, "average": 0.998439, "min": 0.996327}, "location": {"width": 148, "top": 1263, "height": 27, "left": 221}, "words": "磷酸西格列汀"}, {"probability": {"variance": 0.003739, "average": 0.986853, "min": 0.626973}, "location": {"width": 828, "top": 1295, "height": 46, "left": 220}, "words": "基于对I期和Ⅱ期数据的人口药代动力学分析,年龄对于西格列汀的药代动力学不"}, {"probability": {"variance": 1.6e-05, "average": 0.997123, "min": 0.983531}, "location": {"width": 831, "top": 1344, "height": 42, "left": 220}, "words": "具有临床意义的影响。老年受试者(65~80岁)西格列汀的血药浓度比青年受试"}, {"probability": {"variance": 1e-06, "average": 0.99867, "min": 0.996597}, "location": {"width": 166, "top": 1403, "height": 29, "left": 223}, "words": "者高出大约19%"}, {"probability": {"variance": 0.013534, "average": 0.938269, "min": 0.680304}, "location": {"width": 147, "top": 1489, "height": 32, "left": 226}, "words": "盐酸二甲双胍"}, {"probability": {"variance": 0.000182, "average": 0.995469, "min": 0.938344}, "location": {"width": 826, "top": 1525, "height": 44, "left": 226}, "words": "从有限的以老年健康受试者为研究对象的二甲双胍对照药代动力学研究来看,与"}], "language": 3}